Delivery Order SPE2DB24D2217-SPE2DB24FJVUW

Award Date 9/17/24
Potential Completion Date 10/8/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of LONSURF 20 MG-8.19 MG tablets. The firm-fixed-price contract has a ceiling value of $6,760.14 and a completion date of April 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 40S, a pharmaceutical product, with a ceiling value of $13,520.28. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $10,173.33. The period of performance extends to July 7, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,791.74 Firm Fixed Price Delivery Order is for the supply of 4565665178 LONSURF 15 MG-6.14 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of September 24, 2024 and was awarded on September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The contract has a firm fixed price of $8,531.96 and an ultimate completion date of September 19, 2024. This contract is not set aside for any particular business type. AmerisourceBergen, through its extensive federal contracting experience and supply chain capabilities, will provide these critical...
This federal contract award, valued at $15,004.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LONSURF 15 MG-6.14 MG TABLET 60S, a pharmaceutical product, with a completion date of December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LONSURF 15 MG-6.14 MG TABLET 20S. The award, with a ceiling value of $9,583.44, was made by the Defense Logistics Agency (DLA) on November 1, 2024 as a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $9,583.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 15 MG-6.14 MG tablets, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of October 7, 2024 and is structured as a firm fixed-price delivery order. AmerisourceBergen holds a significant...
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB24FJVUW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The $8,531.96 firm-fixed-price contract has an ultimate completion date of October 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities, including prescription drugs and supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/17/24, 9:19 AM